Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valganciclovir Effect on Spermatogenesis in Renal Transplant Recipients
NCT01663740Phase 4Completed
- Sponsor
- Roche
- Start
- Jan 2012
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of valganciclovir in cytomegalovirus infection (CMV), sponsored by Roche. Started Jan 2012; status: completed.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT01663740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01663740.